Genetec Balance Sheet Health
Financial Health criteria checks 5/6
Genetec has a total shareholder equity of ¥2.1B and total debt of ¥925.0M, which brings its debt-to-equity ratio to 44%. Its total assets and total liabilities are ¥4.4B and ¥2.3B respectively. Genetec's EBIT is ¥805.0M making its interest coverage ratio 100.6. It has cash and short-term investments of ¥1.2B.
Key information
44.0%
Debt to equity ratio
JP¥925.00m
Debt
| Interest coverage ratio | 100.6x |
| Cash | JP¥1.24b |
| Equity | JP¥2.10b |
| Total liabilities | JP¥2.28b |
| Total assets | JP¥4.38b |
Recent financial health updates
Is Genetec (TSE:4492) Using Too Much Debt?
Nov 11
Does Genetec (TSE:4492) Have A Healthy Balance Sheet?
Aug 02Recent updates
Is Genetec (TSE:4492) Using Too Much Debt?
Nov 11Positive Sentiment Still Eludes Genetec Corporation (TSE:4492) Following 34% Share Price Slump
Aug 05Does Genetec (TSE:4492) Have A Healthy Balance Sheet?
Aug 02Genetec Corporation's (TSE:4492) Popularity With Investors Under Threat As Stock Sinks 27%
May 23Genetec Corporation (TSE:4492) Stock Rockets 38% As Investors Are Less Pessimistic Than Expected
Feb 26Capital Allocation Trends At Genetec (TYO:4492) Aren't Ideal
Mar 28Genetec Corporation (TYO:4492) Has A ROE Of 13%
Nov 23Financial Position Analysis
Short Term Liabilities: 4492's short term assets (¥3.0B) exceed its short term liabilities (¥1.7B).
Long Term Liabilities: 4492's short term assets (¥3.0B) exceed its long term liabilities (¥540.0M).
Debt to Equity History and Analysis
Debt Level: 4492 has more cash than its total debt.
Reducing Debt: 4492's debt to equity ratio has increased from 20% to 44% over the past 5 years.
Debt Coverage: 4492's debt is well covered by operating cash flow (65.1%).
Interest Coverage: 4492's interest payments on its debt are well covered by EBIT (100.6x coverage).